EU FMD Pharma Serialisation Industry Readiness Survey Report 2017 Nov 1, 2017,
by Maria Svejdar - Category: Pharma Serialisation Report focus: EU Falsified Medicines Directive - FMD - pharma serialisation readiness Serialisation Readiness Survey Background
Our joint report on serialisation readiness returns in its second year. This time, we have focused on preparations to meet the impending EU FMD deadline. The survey draws from across the industry, including Pharma Manufacturers, Virtual Pharma Companies, Contract Manufacturers, 3PLs, and Wholesale Distributor Repackagers.
Key findings of the report There is a greater understanding of the financial implications of serialisation for businesses in 2017, when compared to the findings of our 2016 survey With the deadline due in less than 18 months, the survey found that a quarter of those surveyed had no lines ready to meet the requirements of the EU FMD Over 70% of those surveyed had business processes ready to handle master data In over 50% of companies surveyed, a company-wide education programme is not in place to deal with the challenges of serialisation Click here to download Keep up to date on serialisation
To keep up-to-date on serialisation matters and regulatory changes follow
ESP on Twitter and subscribe to the GS1 Ireland Healthcare Newsletter, selecting serialisation as your topic of interest. Tags: EU FMD, Falsified Medicines Directive,